chr19-9811533-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017703.3(FBXL12):c.344G>T(p.Ser115Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000343 in 1,459,384 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_017703.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL12 | NM_017703.3 | c.344G>T | p.Ser115Ile | missense_variant | 3/3 | ENST00000247977.9 | NP_060173.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL12 | ENST00000247977.9 | c.344G>T | p.Ser115Ile | missense_variant | 3/3 | 1 | NM_017703.3 | ENSP00000247977.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249682Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134952
GnomAD4 exome AF: 0.00000343 AC: 5AN: 1459384Hom.: 0 Cov.: 35 AF XY: 0.00000276 AC XY: 2AN XY: 725656
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2024 | The c.344G>T (p.S115I) alteration is located in exon 3 (coding exon 3) of the FBXL12 gene. This alteration results from a G to T substitution at nucleotide position 344, causing the serine (S) at amino acid position 115 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at